We are live on ! Find out more
Jeff Yass

Jeff Yass Susquehanna International Group

AUM $1.28T Turnover 24.66%
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+35.7%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$1.28T
AUM Growth
+$391B
Cap. Flow
+$19.1B
Cap. Flow %
1.49%
Top 10 Hldgs %
26.66%
Holding
15,023
New
1,956
Increased
5,793
Reduced
5,445
Closed
1,748
Avg Time Held Equity + Options
3.8 years
Top 10 Avg Time Held Equity + Options
5.1 years
Top 20 Avg Time Held Equity + Options
5.8 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
1.8 years
Top 20 Avg Time Held Equity only
3.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.8%
2 Technology 2.93%
3 Communication Services 0.62%
4 Consumer Discretionary 0.61%
5 Industrials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BLRX icon
12526
BioLineRX
BLRX
$5.87M
$95.8K ﹤0.01%
+30,911
New +$89.6K
2026 Q2
0 quarters
ACRE icon
12527
Ares Commercial Real Estate
ACRE
$194M
$95.7K ﹤0.01%
21,257
-19,637
-48% -$96.9K
2024 Q4
6 quarters
CERT icon
12528
CALL
Certara
CERT
$1.73B
$95.6K ﹤0.01%
14,600
-83,900
-85% -$473K
2025 Q3
3 quarters
VTGN icon
12529
CALL
VistaGen Therapeutics
VTGN
$8.05M
$95.5K ﹤0.01%
415,400
+375,000
+928% +$226K
2025 Q3
3 quarters
NNBR icon
12530
PUT
NN Inc
NNBR
$272M
$95.5K ﹤0.01%
+26,600
New +$66.2K
2026 Q2
0 quarters
PLX icon
12531
Protalix BioTherapeutics
PLX
$255M
$95.4K ﹤0.01%
40,944
-8,141
-17% -$17.2K
2025 Q1
5 quarters
AMBP icon
12532
PUT
Ardagh Metal Packaging
AMBP
$2.74B
$94.8K ﹤0.01%
20,000
+3,700
+23% +$15.2K
2026 Q1
1 quarter
PCF icon
12533
High Income Securities Fund
PCF
$92.6M
$94.4K ﹤0.01%
+17,254
New +$96.7K
2026 Q2
0 quarters
QTRX icon
12534
CALL
Quanterix
QTRX
$135M
$94.2K ﹤0.01%
21,800
+6,500
+42% +$21.1K
2026 Q1
1 quarter
SKYA icon
12535
SkyAI
SKYA
$107M
$94.1K ﹤0.01%
84,810
+44,486
+110% +$71.3K
2026 Q1
1 quarter
BOSC icon
12536
Better Online Solutions
BOSC
$28.8M
$93.8K ﹤0.01%
20,883
+6,507
+45% +$29.3K
2026 Q1
1 quarter
FSOL icon
12537
CALL
Fidelity Solana Fund
FSOL
$92.8M
$93.5K ﹤0.01%
+10,800
New +$103K
2026 Q2
0 quarters
PYPD icon
12538
PUT
PolyPid
PYPD
$131M
$93.5K ﹤0.01%
+18,400
New +$84.9K
2026 Q2
0 quarters
TGB icon
12539
Trekor Metals
TGB
$2.34B
$93.4K ﹤0.01%
13,571
-700,688
-98% -$5.01M
2026 Q1
1 quarter
PLRX icon
12540
PUT
Pliant Therapeutics
PLRX
$42.8M
$93.4K ﹤0.01%
81,900
-29,600
-27% -$36K
2025 Q2
4 quarters
HLN icon
12541
PUT
Haleon
HLN
$40.4B
$93.3K ﹤0.01%
10,000
-500
-5% -$4.65K
2026 Q1
1 quarter
AIRG icon
12542
Airgain
AIRG
$52.2M
$93.3K ﹤0.01%
14,802
-21,879
-60% -$145K
2026 Q1
1 quarter
HDSN icon
12543
PUT
Hudson Technologies
HDSN
$179M
$93K ﹤0.01%
+16,200
New +$92.2K
2026 Q2
0 quarters
VTSI icon
12544
PUT
VirTra
VTSI
$45.5M
$92.9K ﹤0.01%
29,600
-7,100
-19% -$27K
2021 Q3
19 quarters
ATYR icon
12545
CALL
aTyr Pharma
ATYR
$13.9M
$92.9K ﹤0.01%
3,870
+1,302
+51% +$34K
2024 Q3
7 quarters
ARCO icon
12546
PUT
Arcos Dorados Holdings
ARCO
$1.46B
$92.7K ﹤0.01%
11,500
+1,300
+13% +$11.2K
2026 Q1
1 quarter
RCEL icon
12547
CALL
Avita Medical
RCEL
$491M
$92.5K ﹤0.01%
22,400
+2,700
+14% +$11.6K
2026 Q1
1 quarter
WEAV icon
12548
DELISTED
Weave Communications
WEAV
$92.4K ﹤0.01%
15,423
-77,536
-83% -$422K
2026 Q1
1 quarter
NPWR icon
12549
PUT
NET Power
NPWR
$186M
$92.2K ﹤0.01%
55,200
+11,500
+26% +$20.8K
2025 Q1
5 quarters
MTLS icon
12550
CALL
Materialise
MTLS
$356M
$92.1K ﹤0.01%
12,400
-1,900
-13% -$11.2K
2026 Q1
1 quarter

Similar funds

Jeff Yass's Q2 2026 Portfolio in Review

As of Q2 2026, Jeff Yass held 15,023 positions worth $1.28T, up 44% from $893B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass's Q2 2026 filing shows 1,956 new, 5,793 increased, 5,445 reduced and 1,748 closed positions. Its largest new stake was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M. The largest sale was Invesco QQQ Trust, an estimated $1.78B.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q2 2026 buy was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $2.87B increase.
  • Jeff Yass's biggest Q2 2026 reduction was Invesco QQQ Trust, cutting an estimated $1.78B.
  • Jeff Yass fully exited iShares MSCI Emerging Markets ex China ETF in Q2 2026, selling an estimated $142M.
  • Jeff Yass's ten largest holdings make up 27% of its $1.28T portfolio in Q2 2026.
  • Jeff Yass opened 1,956 new positions and closed 1,748 in Q2 2026.
  • Jeff Yass's portfolio value rose 44% quarter-over-quarter to $1.28T.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.